Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Fluorescence optical imaging in pediatric patients with inflammatory and non-inflammatory joint diseases: a comparative study with ultrasonography.

Beck MC, Glimm AM, Ohrndorf S, Minden K, Trauzeddel R, Werner SG, Horneff G, Backhaus M, Burmester GR, Kallinich T, Girschick H, Klotsche J.

Arthritis Res Ther. 2017 Oct 17;19(1):233. doi: 10.1186/s13075-017-1440-8.

2.

Fluorescence optical imaging and musculoskeletal ultrasonography in juvenile idiopathic polyarticular disease before and during antirheumatic treatment - a multicenter non-interventional diagnostic evaluation.

Klein A, Just GW, Werner SG, Oommen PT, Minden K, Becker I, Langer HE, Klee D, Horneff G.

Arthritis Res Ther. 2017 Jun 30;19(1):147. doi: 10.1186/s13075-017-1355-4.

3.

Transitional care for rheumatic conditions in Europe: current clinical practice and available resources.

Clemente D, Leon L, Foster H, Carmona L, Minden K.

Pediatr Rheumatol Online J. 2017 Jun 9;15(1):49. doi: 10.1186/s12969-017-0179-8.

4.

A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities.

Beukelman T, Anink J, Berntson L, Duffy C, Ellis JA, Glerup M, Guzman J, Horneff G, Kearsley-Fleet L, Klein A, Klotsche J, Magnusson B, Minden K, Munro JE, Niewerth M, Nordal E, Ruperto N, Santos MJ, Schanberg LE, Thomson W, van Suijlekom-Smit L, Wulffraat N, Hyrich K.

Pediatr Rheumatol Online J. 2017 Apr 19;15(1):31. doi: 10.1186/s12969-017-0161-5.

5.

Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPIC.

Weiß A, Minden K, Listing J, Foeldvari I, Sieper J, Rudwaleit M.

RMD Open. 2017 Mar 21;3(1):e000366. doi: 10.1136/rmdopen-2016-000366. eCollection 2017.

6.

Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications.

Ombrello MJ, Arthur VL, Remmers EF, Hinks A, Tachmazidou I, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rosen-Wolff A, Minden K, Tenbrock K, Demirkaya E, Cobb J, Baskin E, Signa S, Shuldiner E, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A; British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis (ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group, Langefeld CD, Thompson S, Zeggini E, Kastner DL, Woo P, Thomson W.

Ann Rheum Dis. 2017 May;76(5):906-913. doi: 10.1136/annrheumdis-2016-210324. Epub 2016 Dec 7.

7.

Juvenile arthritis caused by a novel FAMIN (LACC1) mutation in two children with systemic and extended oligoarticular course.

Kallinich T, Thorwarth A, von Stuckrad SL, Rösen-Wolff A, Luksch H, Hundsdoerfer P, Minden K, Krawitz P.

Pediatr Rheumatol Online J. 2016 Nov 24;14(1):63.

8.

Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab.

Horneff G, Klein A, Klotsche J, Minden K, Huppertz HI, Weller-Heinemann F, Kuemmerle-Deschner J, Haas JP, Hospach A.

Arthritis Res Ther. 2016 Nov 24;18(1):272.

9.

The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort.

Sengler C, Klotsche J, Niewerth M, Liedmann I, Föll D, Heiligenhaus A, Ganser G, Horneff G, Haas JP, Minden K.

RMD Open. 2015 Dec 8;1(1):e000074. doi: 10.1136/rmdopen-2015-000074. eCollection 2015.

10.

Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.

Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J.

Arthritis Care Res (Hoboken). 2016 Jan;68(1):46-54. doi: 10.1002/acr.22649.

11.

Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven years.

Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhaes C, Chavez-Corrales J, Huemer C, Kivitz A, Blanco FJ, Foeldvari I, Hofer M, Huppertz HI, Job Deslandre C, Minden K, Punaro M, Block AJ, Giannini EH, Martini A; Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation.

Arthritis Rheumatol. 2015 Oct;67(10):2759-70. doi: 10.1002/art.39234.

12.

Uveitis in juvenile idiopathic arthritis.

Heiligenhaus A, Minden K, Föll D, Pleyer U.

Dtsch Arztebl Int. 2015 Feb 6;112(6):92-100, i. doi: 10.3238/arztebl.2015.0092. Review.

13.

Effect of methotrexate on the mandibular development of arthritic rabbits.

Präger TM, Meyer P, Rafayelyan S, Minden K, Jost-Brinkmann PG.

Eur J Orthod. 2015 Oct;37(5):514-21. doi: 10.1093/ejo/cju070. Epub 2014 Dec 17.

14.

Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement.

Horneff G, Fitter S, Foeldvari I, Minden K, Kuemmerle-Deschner J, Tzaribacev N, Thon A, Borte M, Ganser G, Trauzeddel R, Huppertz HI.

Arthritis Res Ther. 2012 Oct 24;14(5):R230. doi: 10.1186/ar4072.

15.

Progress in pediatric rheumatology: apprehend the opportunities of the future without forgetting the lessons from the past.

Huppertz HI, Föll D, Girschick H, Minden K, Horneff G.

Rheumatol Int. 2011 Oct;31(10):1259-62. doi: 10.1007/s00296-011-2062-0. Epub 2011 Sep 8. No abstract available.

16.

Tumour necrosis factor receptor associated periodic syndrome (TRAPS) with central nervous system involvement.

Minden K, Aganna E, McDermott MF, Zink A.

Ann Rheum Dis. 2004 Oct;63(10):1356-7. No abstract available.

17.

Burden and cost of illness in patients with juvenile idiopathic arthritis.

Minden K, Niewerth M, Listing J, Biedermann T, Schöntube M, Zink A.

Ann Rheum Dis. 2004 Jul;63(7):836-42.

18.

Writing papers and changing minds.

Schipper H, Minden K.

CMAJ. 1994 Apr 1;150(7):1075-8. No abstract available.

Supplemental Content

Loading ...
Support Center